Perioperative Inflammation and Breast Cancer Outcome

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Samsung Medical Center
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Ibuprofen; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Breast cancer patients who took the surgery

Exclusion Criteria:

• underlying medical disease (major heart disease, lung disease, coagulopathy)

• major psychologic disease (major depression, schizophrenia, manic disorder)

• pregnancy

• rheumatic disease patients